PEII Up +15.92% With +0.0039 Gain $.0284 – Petron Energy II $.0284, Elite Pharmaceuticals $.10 (OTCBB:PEII, OTCBB:ELTP)

Petron Energy II Inc. (PEII)

Petron Energy II Inc. (OTCBB:PEII) (www.petronenergyii.com) is a Dallas-based, oil and gas exploration and production company.

Today, PEII has surged (+15.92%) up +0.0039 at $.0284 with 4,459,287 shares in play thus far (ref. google finance Delayed: 1:19PM EDT August 13, 2013), but don’t let this get you down.

PEII daily range is at ($.0338 – $.024) thus far and currently at $.0284 would be considered a (+184%) gain above the 52 wk low of $.01.

Petron Energy II Inc. (PEII) 5 day chart:

The Company reported today that they projects that if it can continue its current pace of production improvements and successfully earn its second tranche against its $5 million line of credit from TCA Global Credit Master Fund, LP (“TCA”), there is a strong possibility that it will become profitable by late 2nd quarter 2014.

Petron Energy II, Inc., (“PEII”, “Petron Energy II” or the “Company”) together with its subsidiaries, engages in the acquisition and development of properties for the production of crude oil and natural gas, transporting natural gas through its pipeline subsidiary and well servicing through its servicing subsidiary, in the United States.

****

Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals, Inc. (OTCBB:ELTP) (www.elitepharma.com) is a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and controlled release product formulations and generics with high barriers to entry.

Today, ELTP has surged (+16.65%) up +0.01 at $.10 with 3,619,254 shares in play thus far (ref. google finance Delayed: 1:25PM EDT August 13, 2013), but don’t let this get you down.

ELTP daily range is at ($.0997 – $.0835) thus far and currently at $.10 would be considered a (+100%) gain above the 52 wk low of $.05.

Elite Pharmaceuticals, Inc. (ELTP) 5 day chart:

The Company reported today the Company will host a conference call on Thursday, August 15, 2013 at 3:00 PM EDT to review the first quarter results of operations and provide an update on recent business developments. Company executives will also conduct a question and answer session following their remarks.

To access the conference call:
Domestic callers: (800) 346-7359
International callers: (973) 528-0008
Conference Entry Code: 98840

Elite Pharmaceuticals, Inc. (“ELTP”, “Elite Pharmaceuticals” or the “Company”) develops oral sustained and controlled release products. Elite’s strategy includes assisting partner companies in the life cycle management of products to improve off-patent drug products and developing generic versions of controlled release drug products with high barriers to entry.

Remember: Always do your homework and consult your own financial professional.

http://crweselect.com/38807/stock-alerts/peii-up-15-92-with-0-0039-gain-0284-petron-energy-ii-0284-elite-pharmaceuticals-10-otcbbpeii-otcbbeltp/